(DAE) Daetwyl I - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0030486770

DAE: Rubber Components, Sealing Solutions, Elastomer Parts, Medical Devices

Dätwyler Holding AG is a Swiss-based company that specializes in the production and sale of elastomer components, catering to a diverse range of industries including healthcare, mobility, connectors, and food and beverage, across various regions such as Europe, North America, South America, Australia, and Asia. The company's operations are divided into two primary segments: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment focuses on developing rubber components for medical devices, such as prefilled syringes, injection systems, and blood collection systems, as well as components and closures for injectable drugs and disposable syringes.

The Industrial Solutions segment, on the other hand, produces a wide range of components for various industries, including electric vehicles, where its products are used in batteries and powertrains, as well as in combustion engines for fuel and engine management and exhaust gas aftertreatment. Additionally, this segment manufactures seals and components for electrical connectors, sealing solutions for aerospace and heavy machinery, and sealing components for upstream systems, power tools, water, and process and treatment industries. This diversified product portfolio enables Dätwyler Holding AG to maintain a strong presence in multiple markets.

With a history dating back to 1915, Dätwyler Holding AG has established itself as a reputable player in the industry, operating as a subsidiary of Pema Holding AG. The company's commitment to innovation and quality has allowed it to expand its global reach, serving customers across different continents. As a publicly traded company, Dätwyler Holding AG's common stock is listed under the ISIN CH0030486770, and it is classified under the GICS Sub Industry of Trading Companies & Distributors. For more information, investors and customers can visit the company's website at https://www.datwyler.com.

Additional Sources for DAE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DAE Stock Overview

Market Cap in USD 2,480m
Sector Industrials
Industry Industrial Distribution
GiC Sub-Industry Trading Companies & Distributors
IPO / Inception

DAE Stock Ratings

Growth 5y -31.8%
Fundamental 58.6%
Dividend 44.5%
Rel. Strength Industry -207
Analysts -
Fair Price Momentum 119.93 CHF
Fair Price DCF 513.94 CHF

DAE Dividends

Dividend Yield 12m 2.40%
Yield on Cost 5y 2.03%
Annual Growth 5y 1.30%
Payout Consistency 91.7%

DAE Growth Ratios

Growth Correlation 3m -78.3%
Growth Correlation 12m -78.6%
Growth Correlation 5y -32.8%
CAGR 5y -3.27%
CAGR/Mean DD 5y -0.10
Sharpe Ratio 12m -1.12
Alpha -41.24
Beta 0.56
Volatility 27.64%
Current Volume 4.1k
Average Volume 20d 10.9k
What is the price of DAE stocks?
As of January 21, 2025, the stock is trading at CHF 133.40 with a total of 4,067 shares traded.
Over the past week, the price has changed by +5.01%, over one month by +0.75%, over three months by -12.06% and over the past year by -24.90%.
Is Daetwyl I a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Daetwyl I (SW:DAE) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.63 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DAE as of January 2025 is 119.93. This means that DAE is currently overvalued and has a potential downside of -10.1%.
Is DAE a buy, sell or hold?
Daetwyl I has no consensus analysts rating.
What are the forecast for DAE stock price target?
According to ValueRays Forecast Model, DAE Daetwyl I will be worth about 130.2 in January 2026. The stock is currently trading at 133.40. This means that the stock has a potential downside of -2.38%.
Issuer Forecast Upside
Wallstreet Target Price 169.8 27.3%
Analysts Target Price - -
ValueRay Target Price 130.2 -2.4%